Leading stem cell bank LifeCell International on Tuesday said it has raised Rs 255 crore in a funding round led by healthcare investment firm OrbiMed Asia Partners IV. The founders of LifeCell also participated in the round, LifeCell International Pvt Ltd said in a statement. While OrbiMed Asia Partners IV has put in Rs 225 crore, existing partners have put in Rs 30 crore, it added.
“With demonstrated market leadership across segments, LifeCell seeks to further leverage its technological expertise, strong brand position, and wide network to foray into adjacent new categories like Fertility Heath and Cell-based therapeutics,” LifeCell International MD Mayur Abhaya said. These funds will help accelerate this agenda and further strengthen the company’s market position, he added.
OrbiMed Asia Senior Managing Director Sunny Sharma will join the Board of LifeCell upon closure of this transaction, LifeCell said. “LifeCell has built a trusted healthcare brand in maternal and newborn health through innovation and service. We are very excited to partner with Mayur and his team in the next stage of LifeCell’s growth,” Sharma said.
Pingback: Kharif foodgrain output estimated at record 150.50 million tonne this year: Govt
Pingback: DoT issues order to enable door-step delivery of SIM cards
Pingback: FrontRow, a learning platform for non-academic skills, raises USD 14 mn
Pingback: Centre launches National Single Window System for investors, businesses
Pingback: CareerLabs ties up with Tech Mahindra to upskill 3000 graduates